Therefore, due to the high proportion of NATAM ancestry in the Ecuadorian population and its association with the CYP2C8*1 variant (wild type), the present results suggest that TZDs may represent a safe and effective treatment option for Ecuadorian patients with T2DM. The gene discussed is CYP2C8; the disease is type 2 diabetes mellitus.